Schonfeld Strategic Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
|
|||||
|
2025
Q1 | $1.08M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $468K | Buy |
|
|||||
|
2024
Q2 | $370K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $484K | Buy |
|
|||||
|
2023
Q3 | $366K | Sell |
|
|||||
|
2023
Q2 | $19.3M | Sell |
|
|||||
|
2023
Q1 | $104M | Buy |
|
|||||
|
2022
Q4 | $76.3M | Buy |
|
|||||
|
2022
Q3 | $73M | Sell |
|
|||||
|
2022
Q2 | $152M | Buy |
|
|||||
|
2022
Q1 | $92.9M | Sell |
|
|||||
|
2021
Q4 | $129M | Sell |
|
|||||
|
2021
Q3 | $138M | Buy |
|
|||||
|
2021
Q2 | $74.9M | Sell |
|
|||||
|
2021
Q1 | $70.4M | Buy |
|
|||||
|
2020
Q4 | $55.6M | Buy |
|
|||||
|
2020
Q3 | $18.5M | Sell |
|
|||||
|
2020
Q2 | $16.9M | Buy |
|
|||||
|
2020
Q1 | $10.4M | Sell |
|
|||||
|
2019
Q4 | $38.1M | Buy |
|
|||||
|
2019
Q3 | $27.2M | Buy |
|
|||||
|
2019
Q2 | $18.6M | Buy |
|
|||||
|
2019
Q1 | $5.26M | Buy |
|
|||||
|
2018
Q4 | $2.04M | Buy |
|
|||||
|
2018
Q3 | $1.88M | Sell |
|
|||||
|
2018
Q2 | $10.8M | Buy |
|
|||||
|
2018
Q1 | $381K | Sell |
|
|||||
|
2017
Q4 | $1.16M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $294K | Sell |
|
|||||
|
2016
Q4 | $584K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $309K | Buy |
|